EFFICACY AND SAFETY OF SYSTEMIC CHEMOTHERAPY IN PATIENTS WITH ADVANCED MYCOSIS FUNGOIDES AND SEZARY SYNDROME: A RETROSPECTIVE STUDY OF 94 CASES

被引：0
|
作者：
Henao Viviana, Paredes [1 ]
Eva, Gonzalez-Barca [1 ]
Eva, Domingo [1 ]
Santiago, Mercadal [1 ]
Esmeralda, De La Banda [1 ]
Fina, Climent [1 ]
Cristina, Muniesa [1 ]
Anna, Sureda [1 ]
De Sevilla Alberto, Fernandez [1 ]
Teresa, Estrach [2 ]
Guillermo Armando, Lopez [2 ]
Octavio, Servitje [1 ]
机构：
[1] Hosp Univ Bellvitge, Ico, Lhospitalet De Llobregat, Spain
[2] Hosp Clin Barcelona, Barcelona, Spain
来源：
HAEMATOLOGICA | 2016年 / 101卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PC-253
引用
收藏
页码：230 / 231
页数：2
相关论文
共 50 条
  • [1] Mogamulizumab in the treatment of advanced mycosis fungoides and Sezary syndrome: safety and efficacy
    Lewis, Daniel J.
    Rook, Alain H.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (06) : 447 - 452
  • [2] Alemtuzumab in patients with advanced mycosis fungoides and Sezary syndrome
    Beltran-Garate, Brady
    Gomez, Henry
    Lopez, Jose L.
    Borrego, Mildred
    Prieto, Mercedes
    Carrasco-Yalan, Antonio A.
    Huamani, Julia
    Castillo, Jorge
    Da Costa, Osiris
    BLOOD, 2007, 110 (11) : 1003A - 1004A
  • [3] FLUDARABINE IN PATIENTS WITH ADVANCED MYCOSIS FUNGOIDES/SEZARY SYNDROME
    Ocroteala, L.
    Fraticiu, N.
    Gaman, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 561 - 561
  • [4] Current systemic therapeutic options for advanced mycosis fungoides and Sezary syndrome
    Janiga, Jenna
    Kentley, Jonathan
    Nabhan, Chadi
    Abdulla, Farah
    LEUKEMIA & LYMPHOMA, 2018, 59 (03) : 562 - 577
  • [5] Treatment of patients with advanced mycosis fungoides and Sezary syndrome with alemtuzumab
    Kennedy, GA
    Seymour, JF
    Wolf, M
    Januszewicz, H
    Davison, J
    McCormack, C
    Ryan, G
    Prince, HM
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 71 (04) : 250 - 256
  • [6] Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sezary Syndrome
    Photiou, Louise
    van der Weyden, Carrie
    McCormack, Christopher
    Prince, H. Miles
    CURRENT ONCOLOGY REPORTS, 2018, 20 (04)
  • [7] CHEMOTHERAPY FOR MYCOSIS-FUNGOIDES AND THE SEZARY-SYNDROME
    ROSEN, ST
    FOSS, FM
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1995, 9 (05) : 1109 - +
  • [8] Clinical characteristics of black patients with mycosis fungoides and sezary syndrome: A retrospective cohort study
    Talluru, S. M.
    Cataluna, I. M.
    Samuel, C.
    Rozati, S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (08) : S119 - S119
  • [9] Lack of durable disease control with chemotherapy for mycosis fungoides and Sezary syndrome: a comparative study of systemic therapy
    Hughes, Charlotte F. M.
    Khot, Amit
    McCormack, Christopher
    Lade, Stephen
    Westerman, David A.
    Twigger, Robert
    Buelens, Odette
    Newland, Kate
    Tam, Constantine
    Dickinson, Michael
    Ryan, Gail
    Ritchie, David
    Wood, Colin
    Prince, H. Miles
    BLOOD, 2015, 125 (01) : 71 - 81
  • [10] A retrospective comparative outcome analysis following systemic therapy in Mycosis fungoides and Sezary syndrome
    Hanel, Walter
    Briski, Robert
    Ross, Charles W.
    Anderson, Thomas F.
    Kaminski, Mark S.
    Hristov, Alexandra C.
    Wilcox, Ryan A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (12) : E491 - E495
12345